Human kallikrein 6 (KLK6) was identified based on its transient upregulation in a primary breast tumor and its subsequent silencing in a metastatic tumor from the same patient...
Keywords: aberrant expression, alternative promoters, breast cancer, DNA methylation, gene silencing, human kallikrein 6 (protease M/zyme/neurosin)